Global Biliary Stent Systems Market Size By Type (Conventional Un-covered Stent, Hybrid weaving type Stent), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Biliary Stent Systems Market was valued at USD 478 million in 2023 and is expected to reach USD 792 million by 2031, growing at a CAGR of 6.5% during the forecast period from 2023 to 2031. The increasing prevalence of biliary tract diseases, including bile duct obstruction, gallstones, and cholangiocarcinoma, is driving the demand for minimally invasive treatment options such as biliary stenting. Technological advancements in stent materials, including the development of self-expanding metal stents (SEMS) and fully covered stents, further contribute to market growth. Additionally, the aging global population and rising incidence of hepatobiliary cancers are fueling the expansion of this market.

Drivers:

Rising Incidence of Biliary Disorders:

Growing occurrences of conditions such as bile duct obstruction, pancreatitis, and malignant tumors are significantly boosting the adoption of biliary stent systems for palliative and therapeutic interventions.

Shift Towards Minimally Invasive Procedures:

The medical community is increasingly adopting endoscopic and percutaneous techniques due to their lower complication rates, faster recovery, and cost-effectiveness. Biliary stent systems play a critical role in these procedures.

Technological Advancements in Stent Design:

Innovations such as drug-eluting stents, biodegradable stents, and improved stent coatings are improving patient outcomes and driving product preference among healthcare providers.

Restraints:

Post-procedural Complications:

Risks such as stent migration, occlusion, and infections remain key concerns, potentially deterring widespread adoption in certain patient groups.

High Treatment Costs in Developing Economies:

The relatively high cost of biliary stent procedures and limited reimbursement in low- and middle-income countries could hinder market growth.

Opportunity:

Growth in Emerging Healthcare Markets:

Improving healthcare infrastructure and increased healthcare spending in Asia-Pacific, Latin America, and the Middle East offer untapped opportunities for biliary stent manufacturers.

Expansion of Cancer Treatment Facilities:

The growing number of cancer care centers and specialized gastroenterology departments is creating demand for advanced biliary interventions globally.

Market by System Type Insights:

In 2023, the Self-Expanding Metal Stents (SEMS) segment held the largest share of the market due to their superior patency rates and longer lifespan compared to plastic stents. SEMS are increasingly used in both benign and malignant biliary obstructions. Meanwhile, Plastic Stents continue to find use in short-term applications and pre-surgical biliary decompression, but are expected to grow at a slower pace due to higher complication rates.

Market by End-use Insights:

Hospitals dominated the biliary stent systems market in 2023, accounting for over 60% of the global revenue. Hospitals benefit from the availability of skilled gastroenterologists and advanced imaging technologies necessary for stent placement. Ambulatory Surgical Centers (ASCs) are expected to witness the fastest growth during the forecast period owing to the rising trend of outpatient endoscopic procedures and reduced hospitalization costs.

Market by Regional Insights:

North America led the global biliary stent systems market in 2023 due to advanced healthcare infrastructure, early adoption of innovative medical technologies, and a high incidence of gastrointestinal cancers. Asia-Pacific is projected to grow at the highest CAGR through 2031, driven by increasing awareness, rapid urbanization, and rising investments in healthcare systems in countries like India, China, and South Korea.

Competitive Scenario:

Key players in the global biliary stent systems market include:

Boston Scientific Corporation

Cook Medical

Olympus Corporation

Medtronic plc

Taewoong Medical Co., Ltd.

CONMED Corporation

Becton, Dickinson and Company (BD)

BVM Medical Limited

Micro-Tech Endoscopy

Endo-Flex GmbH

These companies focus on continuous innovation, regulatory approvals, strategic partnerships, and product portfolio expansions to solidify their market position.

Scope of Work – Global Biliary Stent Systems Market

Report Metric Details

Market Size (2023) USD 478 million

Projected Market Size (2031) USD 792 million

CAGR (2023–2031) 6.5%

Market Segments System Type (Plastic Stents, SEMS), End-Use (Hospitals, ASCs), Region

Growth Drivers Rise in biliary disorders, shift to minimally invasive treatments, tech innovation

Opportunities Emerging markets, expansion of cancer care infrastructure

Key Market Developments:

March 2024: Boston Scientific received FDA approval for its next-gen fully covered SEMS, featuring improved anti-migration technolog